SYMPOSIUM - GIANT CELL TUMOR
Year : 2007 | Volume
: 41 | Issue : 2 | Page : 139--145
Giant cell tumor - distal end radius: Do we know the answer?
Yogesh Panchwagh1, Ajay Puri2, Manish Agarwal2, Chetan Anchan1, Mandip Shah1
1 Bone and Soft Tissue Unit, Dept. of Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India
2 Orthopaedic Oncologist, Dept. of Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India
Background: The distal end of the radius is one of the common sites of involvement in giant cell tumors (GCTs) with reportedly increased propensity of recurrence. The objective of the present analysis was to study the modalities of management of the different types of distal end radius GCTs so as to minimize the recurrence rates and retain adequate function.
Materials and methods: Twenty-four patients of distal end radius GCTs treated between January 2000 and December 2004 were retrospectively reviewed. Nineteen cases were available for follow-up with an average follow-up of 37.5 months. There was one Campanacci Grade 1 lesion, nine Grade 2 and 14 Grade 3 lesions. Thirteen (54%) of these patients were treated elsewhere earlier and presented with recurrence. The operative procedures that were performed were: curettage and cementing (five), curettage and bone grafting (seven), excision and proximal fibular arthroplasty (two), excision and wrist arthrodesis (nine) and excision of soft tissue recurrence (one).
Results: Functional status was evaluated using Musculo Skeletal Tumor Society scoring system which averaged 78%. The recurrence rate was 32%. Complications included local recurrence (six), nonunion at the graft bone junction (one), infection (one), deformity (two), stiffness (two), subluxation (two) and bony metastasis (one).
Conclusions: The majority of patients undergoing curettage were either Campanacci Grade 1 or 2. Patients undergoing curettage and reconstruction had a better functional result (82%) as compared to arthrodesis or fibular arthroplasty (69%). Previous intervention did not appear to increase the recurrence rates. Even though complications occur, judicious decision-making and an appropriate treatment plan can ensure a satisfactory outcome in the majority of cases.
Pvt. O.P.D. Room No. 26, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai - 400 012
|How to cite this article:|
Panchwagh Y, Puri A, Agarwal M, Anchan C, Shah M. Giant cell tumor - distal end radius: Do we know the answer?.Indian J Orthop 2007;41:139-145
|How to cite this URL:|
Panchwagh Y, Puri A, Agarwal M, Anchan C, Shah M. Giant cell tumor - distal end radius: Do we know the answer?. Indian J Orthop [serial online] 2007 [cited 2019 Sep 22 ];41:139-145
Available from: http://www.ijoonline.com/article.asp?issn=0019-5413;year=2007;volume=41;issue=2;spage=139;epage=145;aulast=Panchwagh;type=0